ArticleFrontiers in public health2026
Association of state postpartum depression legislation and maternal mortality in the United States.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Objective: State legislation addressing postpartum depression varies widely across the U.S. and may play a critical role in shaping access to mental health care and supports that influence state level maternal mortality outcomes. This study examined the relationship between U.S. state legislation on postpartum depression (PPD) and state-level maternal mortality rates. Methods: Data from PPD-related legislation in 32 states were reviewed and were categorized based on their scope and funding. State-level maternal mortality data was obtained from the CDC, and uninsured rates from the U.S. Census Bureau's American Community Survey. Results: States with highest policy quality PPD legislation, especially those with funding, and with more PPD-related legislation had lower maternal mortality rates, even after adjusting for uninsured rates. In regression analyses, uninsured rate explained 23% of the variance in maternal mortality; number of PPD policies explained 13%, and PPD policy quality explained 12%. Conclusions: Higher quantity and highest quality of PPD-related state legislation are associated with lower state-level maternal mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.